Fenwick & West represented Morphic Holdings, Inc. in the transaction, and Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY) announced...
You must be a Standard 1 Year member to access this content.
Freshfields Bruckhaus Deringer is representing Johnson & Johnson in the transaction, and Fenwick & West is representing Shockwave Medical. Johnson & Johnson (NYSE: JNJ) and Shockwave Medical,...
You must be a Standard 1 Year member to access this content.
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...
You must be a Standard 1 Year member to access this content.
Snell & Wilmer represented Insight Enterprises in the transaction, and Fenwick & West represented SADA. Insight Enterprises (NASDAQ:NSIT) announced it has completed the acquisition of SADA, a leading cloud...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Standard BioTools Inc. on the transaction, and Fenwick & West advised SomaLogic, Inc. Standard BioTools Inc. (Nasdaq: LAB) and SomaLogic (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati is representing Pacific Biosciences, and Fenwick & West is representing Apton Biosystems in the transaction. 8Pacific Biosciences of California (NASDAQ: PACB) (PacBio) announced...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP represented Chinook Therapeutics, Inc. on the transaction, while Hogan Lovells US LLP represented Novartis AG. Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company, announced...
You must be a Standard 1 Year member to access this content.
Fenwick advised Paragraf on the deal. Paragraf, a producer graphene electronics using transfer-free graphene and standard semiconductor processes, announced its acquisition of Cardea Bio, a producer of...
You must be a Standard 1 Year member to access this content.
Fenwick represented Aceragen on the deal, Morgan Lewis advised Idera Pharmaceuticals. Aceragen, a privately-held biotechnology company addressing rare, orphan pulmonary and rheumatic diseases for which there...
You must be a Standard 1 Year member to access this content.
Wachtell Lipton and Skadden advised Adobe on the deal. Fenwick & West advised Sigma while Gunderson Dettmer represented clients Index Ventures, Kleiner Perkins and Greylock Partners....
You must be a Standard 1 Year member to access this content.
Foros acted as financial advisor and Fenwick & West and Slaughter and May acted as legal advisor to Zuora. Stifel acted as financial advisor and Cooley...
You must be a Standard 1 Year member to access this content.
